Dr Reddy's files reponse to the USFDA
This was in reply to the critical observations made in respect of three of the company's manufacturing facilities by the US drug regulator
BS Reporter Hyderabad Dr Reddy's Laboratories Limited today informed the Bombay Stock Exchange that it has submitted response to the US Food and Drug Administration (USFDA) on Monday. This was in reply to the critical observations made in respect of three of the company's manufacturing facilities by the US drug regulator in a warning letter issued to the company on November 5.
The company was given extension of time till December 7 to submit its responses in modification of an earlier directive by the USFDA. Earlier the US drug regulator asked the company to file response with corrective steps within 15 days from the date of receipt of the warning letter
 "Dr Reddy's files reponse to the USFDA")
